Glycerin
FDA Label NDC 17856-0222

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Atlantic Biologicals Corp. for the product Glycerin (NDC 17856-0222). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient (in each suppository), purpose, uses, warnings, ask a doctor before using any laxative if child has, stop use and consult a doctor if child has, keep out of reach of children., directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient (In Each Suppository)

Glycerin 1.2 g

Purpose

Laxative

Uses

  • for relief of occasional constipation
  • this product generally produces a bowel movement in 1/4 to 1 hour

Warnings

For rectal use only

May cause rectal discomfort of burning sensation

Directions

Single daily dosage

Children 2 to under 6 years                      1 suppository, or as directed by a doctor

children under 2 years                              ask a doctor

Insert suppository well up into rectum.

Suppository need not melt completely to produce laxative action.

Other Information

  • Store container tightly closed.
  • Keep away from excessive heat.

Inactive Ingredients

purified water, sodium hydroxide, stearic acid

Pediatriic Glycerin Suppositories

The product shown represents a sample of that currently in use. Additional packaging may also be available.

Pediatric Glycerin Suppositories 30 & 60 per cases. 

Distributed by:

ATLANTIC BIOLOGICALS CORP.

MIAMI, FL 33179

* Please review the disclaimer below.